Gilead Sciences, Inc. (NASDAQ:GILD) shares fell nearly 4% in the extended session Thursday after the biotech giant released its third-quarter results, showing weaker sales …
Cantor: CELG pipeline needs commercial juice; Cowen: Sarepta soars on strong Exondys 51 orphan launch.
Neos Therapeutics Inc (NASDAQ:NEOS) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 37% upturn. …
Eric Schmidt worries CELG investors will further question franchises’ longevity in the 3Q earnings aftermath.
By Bret Jensen Small biotech stocks especially ‘Tier 3‘ concerns like Omeros and Flexion Therapeutics have been taking it on the shin for most …
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) announced that five company-sponsored abstracts will be presented at the 2017 American College of Allergy, Asthma and Immunology (ACAAI) …
Drug maker Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reported a beat and raise this quarter both on the top and bottom-line for Q3 2017. During …
Evercore ISI: Teva throws lawsuit at competitor Lilly; Guggenheim: OCUL’s assets looking at $$$ billions.
Neil Maruoka highlights encouraging prospects for AUPH lead asset in lupus nephritis after Analyst Day.
Today, Atossa Genetics Inc (NASDAQ:ATOS) investors are scratching their heads as to why the stock collapsed following the news that the company’s breast …
